Percutaneous Nephrolithiasis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2019-12-16
Clinical Trial Update: The Minimal Effective Volume (MEV90) of Ropivacaine 0.75% for Ultrasound-guided Transmuscular Quadratus Lumborum Block [Phase 4]
A Phase 4 trial investigating the minimal effective volume (MEV90) of ropivacaine 0.75% for an ultrasound-guided transmuscular quadratus lum…